Sonoma Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

4. Accounts Receivable

12 Months Ended

Mar. 31, 2019

NOTE 4 – Accounts Receivable

Accounts receivable, net consists of the following:

	March 31,
	2019			2018
Accounts receivable	$	3,948,000		$	2,829,000
Less: allowance for doubtful accounts		(24,000	)		(17,000	)
Less: discounts, rebates, distributor fees and returns		(443,000	)		(1,275,000	)
	$	3,481,000		$	1,537,000